TYPICAL FEATURES OF PRIMARY DRUG RESISTANCE AND VIABILITY OF MYCOBACTERIA IN TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
https://doi.org/10.21292/2075-1230-2017-95-2-16-20
Abstract
Goal: to study the structure, profile of primary drug resistance and viability of mycobacteria in tuberculosis patients with concurrent HIV infection.
Materials and methods. Structure, profile of primary drug resistance and viability of mycobacteria were studied in 67 pulmonary tuberculosis patients with concurrent HIV infection.
Results. It has been found out that new drug resistance tuberculosis in those suffering from HIV infection is characterized by severe structure of drug resistance with obvious predominance of multiple (73.1%) and extensive (16.4%) primary drug resistance combined with resistance to main and reserve TB drugs in the majority of cases. Nearly total primary drug resistance to isoniazid, streptomycin and rifampicin has been observed as well as severe burden of TB strains resistant to reserve drugs among which special attention is to be paid to resistance to ofloxacin, detected in the each 4th patient. The above features of drug resistance in tuberculosis patients with concurrent HIV infection create significant difficulties for compilation of the proper regimen of TB drugs for chemotherapy as per regimens IV and V thus inevitably deteriorating treatment efficiency and significantly increasing mortality of such patients.
About the Authors
N. M. Koretskaya
V. F. Voyno-Yasenetsky State Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of Tuberculosis Department with PO Training,
1, Partizana Zheleznyaka St., Krasnoyarsk, 660022
I. A. Bolshakova
V. F. Voyno-Yasenetsky State Medical University
Russian Federation
Russian Federation
Candidate of Medical Sciences, Associate Professor, Associate Professor of Tuberculosis Department with PO Training,
1, Partizana Zheleznyaka St., Krasnoyarsk, 660022
References
1. Borovitskiy V.S. Tuberculosis with extensive drug resistance and HIV infection. Pulmonoloiya, 2013, no. 2, pp. 109-113. (In Russ.)
2. Bochanova T.N., Sitnikova S.V., Mordyk А.V. et al. Clinical and X-ray specific manifestations of tuberculosis in HIV patients depending on the stage of disease. Mezhregion. nauch.-prakt. konferentsiya Аktualnye voprosy okazaniya meditsinskoy pomoschi bolnym tuberkulezom v sovremennykh usloviyakh. [Interregional Scientific Practical Conference on Actual Issues of Medical Care Provision for Tuberculosis Patients under Current Conditions]. Omsk, 2013, Part I, pp. 87-89. (In Russ.)
3. Vishnevskiy B.I., Ivanova L.А., Kolechko N.G. Clinical importance of tuberculosis mycobacteria with various biological properties. Probl. Tub., 1991, no. 5, pp. 49-51. (In Russ.)
4. Dolgova E.А., Аlvares Figeroa M.V., Lobasheva G.P. et al. Definition of drug resistance to rifampicin in tuberculosis patients suffering from secondary diseases induced by HIV infection. Tuberculosis and Lung Diseases, 2014, no. 4, pp. 129-130. (In Russ.)
5. Zimina V.N., Batyrov F.A., Kravchenko А.V. et al. Profile of primary drug resistance in patients with respiratory tuberculosis with concurrent HIV infection. Tuberculosis and Lung Diseases, 2011, no. 8, pp. 31-35. (In Russ.)
6. Koretskaya N.M., Narkevich А.N. Detection and characteristics of respiratory tuberculosis in HIV infection. Аkadem. Journal Zapadnoy Sibiri, 2013, vol. 9, no. 1 (44), pp. 52-53. (In Russ.)
7. Koretskaya N.M., Chushkina А.А., Narkevich А.N. Changes in primary drug resistance in infiltrative pulmonary tuberculosis. Sib. Med. Obozreniye, 2013, no. 1 (79), pp. 66-69. (In Russ.)
8. Kulchavenya E.V., Krasnov V.А., Mordyk А.V. Аlmanakh vnelegochnogo tuberkuleza. [Almanac of extrapulmonary tuberculosis]. Novosibirsk, Sibprint Publ., 2015, 247 p.
9. Mordyk А.V., Ivanova O.G., Sitnikova S.V. Tuberculosis with concurrent HIV infection: causes of treatment failures. Omskiy Nauch. Vestnik, 2015, no. 144, pp. 23-26. (In Russ.)
10. Nechaeva O.B., Skachkova E.I., Kucheryavaya D.А. Tuberculosis monitoring in the Russian Federation. Tuberculosis and Lung Diseases, 2013, no. 12, pp. 40-49. (In Russ.)
11. Panov G.V., Skornyakov S.N., Tsvetkov А.N. et al. Typical features of drug sensitivity of tuberculous mycobacteria isolated in new tuberculosis patients with concurrent HIV infection. Tuberculosis and Lung Diseases, 2015, no. 2, pp. 50-53. (In Russ.)
12. Panteleev A.M. Drug resistant tuberculosis in HIV patients. Аktual. probl. i perspektivy protivotuberkuleznoy sluzhby v RF: Materialy I Kongressa Natsionalnoy assotsiatsii ftiziatrov. [Actual problems and prospectives of TB services in the RF: Materials of the I Congress of the National Association of Phthisiologists]. St. Petersburg, 2012, pp. 281-283. (In Russ.)
13. Pokrovskiy V.V., Ladnaya N.N., Sokolova E.V. HIV infection and tuberculosis in Russia: "both are worse". Tuberculosis and Lung Diseases, 2014, no. 6, pp. 3-8. (In Russ.)
14. Frolova O.P., Schukina I.V., Novoselova O.А. et al. State of the cohort of tuberculosis patients with concurrent HIV infection in the Russian Federation, cross-sector and inter-agency cooperation when providing anti-tuberculosis care to HIV patients. Tuberculosis and Lung Diseases, 2014, no. 4, pp. 26-31. (In Russ.)
Review
For citations:
Koretskaya N.M., Bolshakova I.A. TYPICAL FEATURES OF PRIMARY DRUG RESISTANCE AND VIABILITY OF MYCOBACTERIA IN TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION. Tuberculosis and Lung Diseases. 2017;95(2):16-20. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-2-16-20
Views:
1581
Email this article 